FDA Inspection 1180024 — New Jersey Laboratories

New Jersey Laboratories — FEI 2219935

The FDA completed an inspection of New Jersey Laboratories on Sep 22, 2022 in New Brunswick, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Brunswick, NJ (United States)

Citations

IDCFRDescription
440221 CFR 211.192Written record of investigation incomplete

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.